Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.1041
-0.0308 (-22.83%)
At close: Apr 10, 2026, 4:00 PM EDT
0.1750
+0.0709 (68.11%)
After-hours: Apr 10, 2026, 7:59 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $772.78 thousand as of April 10, 2026. Its market cap has decreased by -85.99% in one year.
Market Cap
772.78K
Enterprise Value
-2.13M
1-Year Change
-85.99%
Ranking
Category
Stock Price
$0.10
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $772.78K, a decrease of -99.63%. That is a compound annual growth rate of -77.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 772.78K | -69.90% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 2.45M |
| Bone Biologics | 2.26M |
| Adial Pharmaceuticals | 2.24M |
| Biodexa Pharmaceuticals | 2.18M |
| Propanc Biopharma | 2.15M |
| Scinai Immunotherapeutics | 2.01M |
| SciSparc | 1.78M |
| CNS Pharmaceuticals | 1.77M |